Dr Datsons Labs to supply anti-malarial drugs to Yemen
04 March 2015 | News | By BioSpectrum Bureau
Dr Datsons Labs to supply anti-malarial drugs to Yemen
(Photo Courtesy: www.thehindu.com)
Dr Datsons Labs announced that it has signed a marketing and distribution deal with Yemen's Al-Mugdh Pharma to sell its anti-malarial drugs in Yemen.
The order is estimated to be about Rs 80 crore, said the company in its filing to BSE.
Mr Sameer Talim, CEO, Dr Datsons Labs, commented, "The talk between the two companies was going on for last six months and there are certain regulatory aspects that need to be addressed before the commercialization of the 5 products to be exported to Al-Mugdh Pharma."
